Medplus Health Services Ltd. · NSE:MEDPLUS
Medplus Health Services — Q1 FY2027 Earnings Presentation
26 slides from Medplus Health Services's earnings presentation, Jul 21, 2026
Slide 1: Cover letter to stock exchanges
MedPlus Health Services Limited July 21, 2026 The Listing Department The Listing Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, Dalal Street, Fort, Bandra Kurla Complex, Mumbai 400 001 Bandra (East), Mumbai – 400 051 BSE Scrip Code: 543427 N
Slide 2: MedPlus Health Services Limited Q1 FY2027 Investor Presentation
MEDPLUS HEALTH SERVICES LIMITED Q1 FY2027 INVESTOR PRESENTATION July 2026
Slide 3: Safe Harbour
Safe Harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by MedPlus Health Services Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for
Slide 4: The MedPlus Story
The MedPlus Story Overview Marked presence of 20 years with network of 5,450+ Stores Spread across 13 states and 1 union territory Cluster based expansion strategy: ‘Continue 2nd Largest Pharma Retailer in the country deeper penetration vs. with pioneer in omni channel Wider reach’ Well curated SKU’
Slide 5: Q1 FY2027 Highlights (1/2)
Results Update Q1 FY2027 Highlights (1/2) ₹ 18,796m Revenue ₹ 4,603m Gross Margin • ₹ 3,370m increase over Q1FY26 • 24.5% GM%, lower by 160 bps yoy, 21.8% yoy lower by 200 bps qoq • ₹ 152m increase over Q4FY26 0.8% qoq • 1.5% decrease in private label over Q1FY26 146 Store Net Additions Stores > 12
Slide 6: Q1 FY2027 Highlights (2/2)
Results Update Q1 FY2027 Highlights (2/2) Revenue, ₹m Gross Margin Operating EBITDA EBITDA, ₹m 18,644 18,796 5.8% 18,061 26.1% 26.1% 26.2% 26.5% 1,898 5.3% 5.4% 1,769 Consolidated 16,793 24.5% 4.7% 1,663 1,531 1,457 15,426 3.5% 1,076 968 887 728 651 18,266 18,399 1,803 17,715 1,688 25.3% 5.6% 1,616
Slide 7: Cluster Based Network Enables Profitable Omni-Channel Service
Cluster Based Network Enables Profitable Omni-Channel Service Overview Stores As On Jun-26 Strong Cluster Based Network Strong network of 5,476 stores across Metros, Tier-One, Tier-Two and beyond. 5,476 stores 2- hour delivery Ability to service 100% market – acute + chronic Online only players cann
Slide 8: Scale Allows A Large Private Label Basket: 1550+ SKUs
Scale Allows A Large Private Label Basket: 1550+ SKUs Overview Pharma Over 900 products covering Chronic, Acute, OTC & Other Pharmaceutical products Non-Pharma Over 650 products covering, packaged food, baked goods, dry goods, cleaning products, cosmetics and toiletries Q1FY27 6
Slide 9: Poised for Growth
Poised for Growth Overview Key Pillars Of Growth MedPlus has an established base of operations in 13 states and 1 union territory. Therefore, we will: Growth in existing clusters and • Further grow in cities where we have market leadership. Metro and Tier - One followed A by Tier - Two and beyond de
Slide 10: Stores Added In Last Months
Results Update 663 Stores Added In Last 12 Months As On Jun-25 As On Mar-26 As On Jun-26 Presence 4,813 5,330 5,476 We are present in stores stores stores 13 states and 1 union territory. 1 1 1 The key urban 1 1 1 centers are: Bangalore, 26 674 43 753 48 758 Chennai, 47 42 55 Hyderabad, 572 175 610
Slide 11: Stores Added In Last Quarter
Results Update 146 Stores Added In Last Quarter Q1 FY27 Openings Q1 FY27 Closures Q1 FY27 Closure Reasons We opened 222 6.5 9.6 222 52* 9 stores in Q1FY27 stores stores There were 52 16 closures 4 5 13 8 3 1 27 22 12 0.7 56 11 42 5 28 7 Relocation Franchisee withdrawn 38 12 6 Others Powered by Bing
Slide 12: Store Network: 27% Less Than Years Old
Results Update Store Network: 27% Less Than 2 Years Old Pharmacy: Count Pharmacy: Age Structure of Stores1 Stores 4.813 4,930 5,112 5,330 5,476 9% 11% 14% 17% 146 19% Openings 218 182 12% 11% 101 117 9% Maintaining 5,000 7% 8% steady store openings 4,000 3,000 5,112 5,330 4,712 4,813 4,930 79% 78% 7
Slide 13: Profitable Older Stores: 12+ Months
Results Update Profitable Older Stores: 12+ Months Store Level Revenue Growth1 Store Level EBITDA Margin Store Level Operating ROCE2,3 17.8% 80.0% 13.1% 77.7% 15.3% 12.4% 11.8% 68.6% 10.9% 10.4% 62.6% 59.8% 10.5% 2.2% -0.2% Q1FY26 Q2FY26 Q3FY26 Q4FY26 Q1FY27 Q1FY26 Q2FY26 Q3FY26 Q4FY26 Q1FY27 Q1FY26
Slide 14: Revenue Mix: Increasing Share Of Private Label
Results Update Revenue Mix: Increasing Share Of Private Label Revenue Mix: By Product Category Revenue Mix3: By Location of Stores 3.9% 4.9% 5.7% 6.3% 7.3% 8.7% 13% 14% 14% 15% 15% 9.6% 10.6% 10.6% 9.3% 12.8% 12.1% 11.6% 11.3% 10.7% 24% 24% 24% 24% 24% 9.5% 9.0% 8.9% 9.3% 9.0% 15% 15% 16% 16% 16% 65
Slide 15: Omni-channel: Profitable With Negligible Acquisition Costs
Results Update Omni-channel: Profitable With Negligible Acquisition Costs Channel Revenue Channel Delivery Pincodes1 and Delivery Hubs 1,100 8.0% 100% Hubs 637 690 699 711 727 1,037 Home Delivery Omni-Channel 7.0% 1,000 3,223 Our online 3,043 3,021 3,077 927 80% 2,935 presence grows 904 6.0% 900 882
Slide 16: Income Statement
Results Update Income Statement Snapshot of Income Statement, ₹m Q1FY27 vs. Q1FY27 vs. Q1FY26 Q4FY26 Q1FY27 Q1FY26 (yoy) Q4FY26(qoq) Revenue 15,426.3 18,643.9 18,796.0 21.8% 0.8% Gross Margin 4,029.0 4,934.4 4,603.1 14.3% -6.7% Gross Margin 26.1% 26.5% 24.5% Expenses 3,300.9 3,858.1 3,951.9 19.7% 2.
Slide 17: Income Statement: Business Segments
Results Update Income Statement: Business Segments Snapshot of Income Statement, ₹m Q4FY26 Q1FY27 Pharmacy Pharmacy Diagnostic Others Total Diagnostic Others Total Retail Retail Revenue 18,265.9 347.8 30.2 18,643.8 18,398.7 370.8 26.5 18,796.0 COGS and Expenses 17,244.1 294.7 28.8 17,567.6 17,810.6
Slide 18: Income Statement: Ind AS Adjustments
Results Update Income Statement: Ind AS Adjustments Snapshot of Income Statement: Ind AS Adjustments, ₹m Q4FY26 Q1FY27 Ind AS Ind AS Ind AS Ind AS Reported Reported Impact Adjusted Impact Adjusted Revenue 18,643.9 - 18,643.9 18,796.0 - 18,796.0 Gross Margin 4,934.4 - 4,934.4 4,603.1 - 4,603.1 Gross
Slide 19: Operating EBITDA Deep Dive
Results Update Operating EBITDA Deep Dive Operating EBITDA Bridge: From 12+ Months Stores to Consolidated, ₹m 707 -41 66 651 -3 588 -78 Operating 12+ Months < 12 Months Pre-Operative Pharmacy Diagnostics Others Consolidated EBITDA Stores Stores* * Includes all Franchisee stores Q1FY27 17
Slide 20: Balance Sheet
Results Update Balance Sheet Key Balance Sheet items, ₹m Jun-25 Mar-26 Jun-26 Assets PPE and CWIP 3,019.9 3,503.4 3,602.6 Inventories 12,729.7 13,816.9 14,395.6 Cash 5,549.3 5,942.1 6,218.8 Liabilities Trade payables 2,797.7 3,069.5 3,595.5 1. Cash includes cash, bank balances and bank deposits Q1FY
Slide 21: Capital Productivity
Results Update Capital Productivity Working Capital Cycle, days ROCE2: Operating EBIT/ Avg. Capital Employed NWC (days) 59 53 53 53 54 26.3% 24.2% 39 22.5% 37 37 Year 1 Stores 35 36 100 days 36 34 17.0% inventory (on 33 33 Year 1 stores 30 revenue) 12.6% Stores Older Than 12 months 19 17 17 17 36 da
Slide 22: Cash Management
Results Update Cash Management Cash Management, Q1FY27, ₹m 3,000 Operating Cash Flow 2,500 ₹ 1,252m Free Cash Flow 2,000 ₹ 161m 1,522 1,500 -159 -112 1,000 -338 500 117 279 -752 0 PBT+ Increase in Taxes Capex Payment Interest Increase D&A+ Int. Working of lease received in cash of Lease Capital liab
Slide 23: Appendix
Appendix A. The Board of Directors and Key Managerial Personnel B. Glossary 21
Slide 24: The Board of Directors and Management Team
A. The Board of Directors and Management Team Appendix Mr. Gangadi Madhukar Reddy Dr. Cherukupalli Bhaskar Reddy Mr. Ajit Pandurang Rangnekar Ms. Aparna Surabhi Mr. Mohan Krishna Reddy Arvabumi Chairman, Managing Director Whole Time Director Additional Director Non-Executive Additional Director and
Slide 25: Glossary
B. Glossary Appendix Term Description Metro: Bengaluru, Chennai (and Avadi), Hyderabad, Kolkata (and Howrah), Mumbai (and Thane) City Categorization Tier One: Ahmednagar, Baramati, Kharagpur, Nagpur, Nashik, Panruti, Pune, Ranaghat, Vijayawada, Visakhapatnam (internal) Tier Two: Hundred and Thirty f
Slide 26: MedPlus Health Services Limited Contact
MEDPLUS HEALTH SERVICES LIMITED Website: www.medplusindia.com INVESTOR RELATIONS Tanushree Chaurasia ir@medplusindia.com MEDIA AND PRESS ENQUIRIES marketing@medplusindia.com Reg. Office: H. No: 11-6-56, Survey No: 257 & 258/1 Opp: IDPL Railway Siding Road, Moosapet, Kukatpally, Hyderabad, Telangana,
MedPlus Health Services — Q1 FY2027 Earnings Presentation on 6ix